Michael Wong joins Roswell Park as physician-in-chief

Brian Druker steps down as CEO of OHSU Knight Cancer Center

On Dec. 3, the faculty and staff members at the OHSU Knight Cancer Institute received an email from Brian J. Druker, the institution’s star scientist, former director, and current CEO, informing them that he would be stepping down from his executive role.

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Andrew M. EvensPhillip ScheinbergThe British Journal of Haematology announced the appointment of Andrew M. Evens as its editor-in-chief, effective Jan. 1, 2025.

December 06, 2024

Vol.50 No.45

Clinical Roundup

Hemokine modulatory regimen shows promise for TNBC in phase I study

A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase I clinical trial for patients with triple-negative breast cancer, the most aggressive type of breast cancer. Results of the study are newly reported in The Journal for ImmunoTherapy of Cancer.

November 22, 2024

Vol.50 No.44

Conversation with The Cancer Letter

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.

A curious piece of paper hangs in a frame outside the director’s office at University of Iowa Holden Comprehensive Cancer Center on the second floor of the General Hospital.

November 01, 2024

Vol.50 No.41

By Paul Goldberg

ACS board member Wayne Frederick steps in as interim CEO, replacing Karen Knudsen
National search will be conducted

Wayne A. I. Frederick, a surgical oncologist and former president of Howard University, will step in as interim chief executive officer of the American Cancer Society, effective Nov. 2.

UChicago Cancer Luminaries podcast interviews Odunsi, Le Beau, and Schilsky about running UCCCC

Two former directors and the current director of the UChicago Medicine Comprehensive Cancer Center appeared in a special episode of the Cancer Luminaries podcast. This series was launched by UCCCC to mark its 50th year as an NCI-designated cancer center.

October 18, 2024

Vol.50 No.39

Michael Wong joins Roswell Park as physician-in-chief

YOU MAY BE INTERESTED IN

Brian Druker steps down as CEO of OHSU Knight Cancer Center

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Hemokine modulatory regimen shows promise for TNBC in phase I study

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.

ACS board member Wayne Frederick steps in as interim CEO, replacing Karen Knudsen
National search will be conducted

UChicago Cancer Luminaries podcast interviews Odunsi, Le Beau, and Schilsky about running UCCCC

Renew today!

Subscriber content

Never miss an issue!

Login

Michael Wong joins Roswell Park as physician-in-chief

YOU MAY BE INTERESTED IN

Brian Druker steps down as CEO of OHSU Knight Cancer Center

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Hemokine modulatory regimen shows promise for TNBC in phase I study

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinicsThe state has the second highest (and rising) cancer rates in the U.S.

ACS board member Wayne Frederick steps in as interim CEO, replacing Karen KnudsenNational search will be conducted

UChicago Cancer Luminaries podcast interviews Odunsi, Le Beau, and Schilsky about running UCCCC

Never miss an issue!

Login

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.

ACS board member Wayne Frederick steps in as interim CEO, replacing Karen Knudsen
National search will be conducted